OBJECTIVE: We combined anchor- and distribution-based methods to establish minimally important differences (MIDs) for six Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer scales in advanced-stage cancer patients. STUDY DESIGN AND SETTING: Participants completed 6 PROMIS-Cancer scales and 23 anchor measures at an initial (n=101) assessment and a follow-up (n=88) assessment 6-12 weeks later. Three a priori criteria were used to identify usable cross-sectional and longitudinal anchor-based MID estimates. The mean standard error of measurement was also computed for each scale. The focus of the analysis was on item response theory-based MIDs estimated on a T-score scale. Raw score MIDs were estimated for comparison purposes. RESULTS: Many cross-sectional (64%) and longitudinal (73%) T-score anchor-based MID estimates were excluded because they did not meet a priori criteria. The following are the recommended T-score MID ranges: 17-item Fatigue (2.5-4.5), 7-item Fatigue (3.0-5.0), 10-item Pain Interference (4.0-6.0), 10-item Physical Functioning (4.0-6.0), 9-item Emotional Distress-Anxiety (3.0-4.5), and 10-item Emotional Distress-Depression (3.0-4.5). Effect sizes corresponding to these MIDs averaged between 0.40 and 0.63. CONCLUSIONS: This study is the first to address MIDs for PROMIS measures. Studies are currently being conducted to confirm these MIDs in other patient populations and to determine whether these MIDs vary by patients' level of functioning.
OBJECTIVE: We combined anchor- and distribution-based methods to establish minimally important differences (MIDs) for six Patient-Reported Outcomes Measurement Information System (PROMIS)-Cancer scales in advanced-stage cancerpatients. STUDY DESIGN AND SETTING:Participants completed 6 PROMIS-Cancer scales and 23 anchor measures at an initial (n=101) assessment and a follow-up (n=88) assessment 6-12 weeks later. Three a priori criteria were used to identify usable cross-sectional and longitudinal anchor-based MID estimates. The mean standard error of measurement was also computed for each scale. The focus of the analysis was on item response theory-based MIDs estimated on a T-score scale. Raw score MIDs were estimated for comparison purposes. RESULTS: Many cross-sectional (64%) and longitudinal (73%) T-score anchor-based MID estimates were excluded because they did not meet a priori criteria. The following are the recommended T-score MID ranges: 17-item Fatigue (2.5-4.5), 7-item Fatigue (3.0-5.0), 10-item Pain Interference (4.0-6.0), 10-item Physical Functioning (4.0-6.0), 9-item Emotional Distress-Anxiety (3.0-4.5), and 10-item Emotional Distress-Depression (3.0-4.5). Effect sizes corresponding to these MIDs averaged between 0.40 and 0.63. CONCLUSIONS: This study is the first to address MIDs for PROMIS measures. Studies are currently being conducted to confirm these MIDs in other patient populations and to determine whether these MIDs vary by patients' level of functioning.
Authors: Kathleen J Yost; Mark V Sorensen; Elizabeth A Hahn; G Alastair Glendenning; Ari Gnanasakthy; David Cella Journal: Value Health Date: 2005 Mar-Apr Impact factor: 5.725
Authors: Dan Turner; Holger J Schünemann; Lauren E Griffith; Dorcas E Beaton; Anne M Griffiths; Jeffrey N Critch; Gordon H Guyatt Journal: J Clin Epidemiol Date: 2009-10-01 Impact factor: 6.437
Authors: Honghu Liu; David Cella; Richard Gershon; Jie Shen; Leo S Morales; William Riley; Ron D Hays Journal: J Clin Epidemiol Date: 2010-08-05 Impact factor: 6.437
Authors: David Cella; David T Eton; Diane L Fairclough; Philip Bonomi; Anne E Heyes; Cheryl Silberman; Michael K Wolf; David H Johnson Journal: J Clin Epidemiol Date: 2002-03 Impact factor: 6.437
Authors: Henrica C W de Vet; Berend Terluin; Dirk L Knol; Leo D Roorda; Lidwine B Mokkink; Raymond W J G Ostelo; Erik J M Hendriks; Lex M Bouter; Caroline B Terwee Journal: J Clin Epidemiol Date: 2009-06-21 Impact factor: 6.437
Authors: Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang Journal: J Rheumatol Date: 2014-11-01 Impact factor: 4.666
Authors: Catherine E Mosher; Joseph G Winger; Barbara A Given; Paul R Helft; Bert H O'Neil Journal: Psychooncology Date: 2015-08-27 Impact factor: 3.894
Authors: Casey M Beleckas; Melissa Wright; Heidi Prather; Aaron Chamberlain; Jason Guattery; Ryan P Calfee Journal: J Hand Surg Am Date: 2018-02-01 Impact factor: 2.230
Authors: Roxanne E Jensen; Carol M Moinpour; Arnold L Potosky; Tania Lobo; Elizabeth A Hahn; Ron D Hays; David Cella; Ashley Wilder Smith; Xiao-Cheng Wu; Theresa H M Keegan; Lisa E Paddock; Antoinette M Stroup; David T Eton Journal: Cancer Date: 2016-10-03 Impact factor: 6.860
Authors: Velda J Gonzalez; Susan McMillan; Elsa Pedro; Maribel Tirado-Gomez; Leorey N Saligan Journal: P R Health Sci J Date: 2018-03 Impact factor: 0.705
Authors: Maisa I Abdalla; Robert S Sandler; Michael D Kappelman; Christopher F Martin; Wenli Chen; Kristen Anton; Millie D Long Journal: Inflamm Bowel Dis Date: 2016-11 Impact factor: 5.325
Authors: Grant R Williams; Allison M Deal; Hanna K Sanoff; Kirsten A Nyrop; Emily J Guerard; Mackenzi Pergolotti; Shlomit S Shachar; Bryce B Reeve; Jeannette T Bensen; Seul Ki Choi; Hyman B Muss Journal: Support Care Cancer Date: 2018-11-27 Impact factor: 3.603
Authors: Karon F Cook; Sally E Jensen; Benjamin D Schalet; Jennifer L Beaumont; Dagmar Amtmann; Susan Czajkowski; Darren A Dewalt; James F Fries; Paul A Pilkonis; Bryce B Reeve; Arthur A Stone; Kevin P Weinfurt; David Cella Journal: J Clin Epidemiol Date: 2016-03-04 Impact factor: 6.437